5,7-Dimethoxychroman-4-one, 95.0%, 100mg

(4-Bromo-2,5-difluorophenyl)boronic acid, 97%, 10g

2-(6-BROMOHEXYL)OXIRANE, 95%, 10g

5-(2-ethoxyphenyl)-1H-pyrazole-4-carboxylic acid, 95.0%, 1g

Methyl 3-Amino-4-methylbenzoate, 97.0%, 1kg

2-Iodo-5-(trifluoromethyl)pyridine, 97.0%, 1g

4-(Trifluoromethyl)benzyl mercaptan, 97.0%, 25g

N-([1,1'-Biphenyl]-4-yl)phenanthren-9-amine>98.0%(GC)1g

Objectif E-Plan phase EPLPH 20x/0,40. Distance de travail 1,85 mm

1-Iodo-2-isopropoxybenzene, 98%, 250mg

(4-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl)boronic acid, 95.0%, 250mg

TERT-BUTYL 2-FLUORO-5-NITROBENZOATE, 95.0%, 1g

Cyclopent-3-ene-1,1-diyldimethanol, 95%, 250mg